Sinocare

Sinocare will invest KRW9.2 billion (USD7.9 million) in EoFlow for a 1.5% stake and form a joint venture in Changsha, China, to integrate blood glucose monitoring with insulin pumps.

Sinocare Inc. held a groundbreaking ceremony for its iPOCT Industrial Park in Changsha High-tech Zone, Hunan. The project involves a 1 billion yuan investment and will include production bases for iCARE, AGEscan, and CGM products.

PTS Diagnostics opened its new 135,000 square foot global headquarters and manufacturing hub in Whitestown, Indiana. The facility features expanded manufacturing and office space and has led to hiring in R&D, operations, and manufacturing.

Sinocare confirmed it is in talks to acquire Johnson & Johnson's diabetes care unit, which includes Lifescan, Animas and Calibra Medical. The deal is not finalized and requires internal review and regulatory approval.